EVolution Therapeutics is delighted to announce that we have joined the 2026 Accelerate@Babraham cohort. Supporting early-stage life science innovation...
News & Events
EVolution Therapeutics joins Innovators Club Cohort VI
We’re excited to share that we’ve secured a place in Innovators Club Cohort VI! The Innovators Club is a 10-week accelerator programme run by the Science...
EVolution Therapeutics Submits Second Patent to Strengthen Platform Innovation
EVolution Therapeutics has submitted its second patent application, marking another important milestone in the development of its RNA-enabled nanoparticle...
EVolution Therapeutics invited as UK representative to present at SPARK Global
EVolution Therapeutics was last week invited to pitch at SPARK Global in Berlin, where co-founder and CTO, Professor Andrew Devitt, had the honour of presenting...
Supporting the Next Generation: MIBTP PhD Student Joins EVolution Therapeutics for 3-Month Placement
EVolution Therapeutics is pleased to welcome PhD student Sasha Kieran for a three-month work experience placement as part of her MIBTP programme. During her time...
EVolution Therapeutics invited to exhibit at Venturefest West Midlands 2024
EVolution Therapeutics was delighted to have been invited to exhibit at Venturefest 2024. Joining an array of innovative start-ups, Dr James Gavin and Alice...
Aston University spotlights new spin-out company, EVolution Therapeutics
Aston University has issued a press release highlighting the work of Evolution Therapeutics and our mission to leverage the pro-resolving properties of...
Welcoming a New Addition to the Team
Exciting news from Evolution Therapeutics as we welcome Alice Wigington, who has joined the team as a Research Scientist. Alice is a first-class graduate of Aston...
EVolution Therapeutics featured in the BBSRC impact showcase
Evolution Therapeutics has been recognised by the Biotechnology and Biosciences Research Council (BBSRC) in their 2023 impact showcase. This showcase serves as a...









